Among the current 18 members of the WFDC family, the most studied elafin (WFDC14) and secretory leukocyte peptidase inhibitor (SLPI) have been reported to be highly expressed in psoriasis lesions (20–22). The gene discussed is PI3; the disease is psoriasis.